Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment Refractory”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01134575
What this trial is testing

CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT05947500
What this trial is testing

Testing the Combination of Two Anticancer Drugs M1774 (Tuvusertib) and Avelumab to Evaluate Their Safety and Effectiveness in Treating Merkel Cell Skin Cancer, MATRiX Trial

Who this might be right for
Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8Locally Advanced Merkel Cell Carcinoma+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00331344
What this trial is testing

Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 100
Not applicableStudy completedNCT02140463
What this trial is testing

Next Generation pErsonalized tX(Therapy) With Plasma DNA Trial-2 in Refractory Solid Tumors (The NEXT-2 Trial)

Who this might be right for
Metastatic Gastrointestinal CancerGenitourinary Cancer
Samsung Medical Center 229
Early research (Phase 1)UnknownNCT03463928
What this trial is testing

A Feasibility and Safety Study of Concomitant Therapy With Allo-CAR-T Cells and Allo-HSCT in Patients With Relapse or Refractory Leukemia

Who this might be right for
B Cell Leukemia
Chinese PLA General Hospital 10
Very early researchUnknownNCT04626765
What this trial is testing

CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Childhood Acute Lymphoblastic Leukemia
Hebei Senlang Biotechnology Inc., Ltd. 50
Testing effectiveness (Phase 2)Study completedNCT02340936
What this trial is testing

Clinical Trial to Determinate Dose, Security and Efficacy or Lenalidomide and Rituximab (LR)-ESHAP in Patients With Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 53
Not applicableLooking for participantsNCT07188311
What this trial is testing

Pucotenlimab Combined With Lenvatinib and Chemotherapy in the Treatment of Advanced, Relapsed/Refractory Hepatoblastoma in Children

Who this might be right for
HepatoblastomaPediatric Cancer
Sun Yat-sen University 24
Testing effectiveness (Phase 2)Ended earlyNCT00427609
What this trial is testing

Bicillin L-A vs Placebo for the Treatment of Chronic, Plaque-Type Psoriasis Unresponsive to Topical Medications

Who this might be right for
Psoriasis
University of Tennessee 5
Large-scale testing (Phase 3)Study completedNCT02076698
What this trial is testing

Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy

Who this might be right for
Partial EpilepsySurgery
University Hospital, Grenoble 62
Early research (Phase 1)Study completedNCT02983695
What this trial is testing

Cannabinoid Therapy for Pediatric Epilepsy

Who this might be right for
Epilepsy
The Hospital for Sick Children 20
Testing effectiveness (Phase 2)Study completedNCT00005836
What this trial is testing

Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT03029598
What this trial is testing

Pembrolizumab and Carboplatin in Treating Patients With Relapsed or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
University of Washington 29
Testing effectiveness (Phase 2)WithdrawnNCT03297463
What this trial is testing

Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma

Who this might be right for
Metastatic MelanomaPulmonary MetastasesHepatic Metastases+1 more
Masonic Cancer Center, University of Minnesota
Not applicableStudy completedNCT02135757
What this trial is testing

Study to Evaluate Real-world Pharmacoeconomics and Resistance Mechanisms of Panitumumab in Metastatic Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer Metastatic
PeriPharm 23
Testing effectiveness (Phase 2)UnknownNCT04153812
What this trial is testing

Clinical Study on the Safety and Effectiveness of Vagus Nerve Stimulation in the Treatment of Refractory Depression

Who this might be right for
Refractory Depression
Xijing Hospital 10
Large-scale testing (Phase 3)Active Not RecruitingNCT06303739
What this trial is testing

Psilocybin-Assisted Therapy in Treatment-Resistant Depression

Who this might be right for
Refractory DepressionTreatment Resistant Depression
University of North Carolina, Chapel Hill 20
Testing effectiveness (Phase 2)Study completedNCT01765244
What this trial is testing

Allogeneic Tissue Engineering (Nanostructured Artificial Human Cornea) in Patients With Corneal Trophic Ulcers in Advanced Stages, Refractory to Conventional (Ophthalmic) Treatment

Who this might be right for
Severe Trophic Corneal Ulcers Refractory to Conventional TreatmentSequelae of Previous Trophic Corneal Ulcers
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud 16
Testing effectiveness (Phase 2)UnknownNCT05318339
What this trial is testing

Trastuzumab and Pyrotinib in HER2 Positive Locally Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Carcinoma, Transitional CellHER-2 Gene Amplification
Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)Study completedNCT00003281
What this trial is testing

Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 84
Next Page
50